Pharmaceuticals
India asked to lead battle against developed world on patent issue
By Nisha Das | 26 Feb 2003
Orchid Pharma's Cephalexin approved by USFDA, EDQM
By Our Corporate Bureau | 24 Feb 2003
Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore
By Nisha Das | 10 Feb 2003
Orchid Chemicals net down to Rs 9.51 cr; turnover at 346.45 cr
By Our Corporate Bureau | 28 Jan 2003
Chemtech + Pharma World Expo to start in Mumbai on 22 Jan
By Our Corporate Bureau | 18 Jan 2003
Zydus Cadila, Berna Biotech tie up to develop cancer vaccines
By Julie Singh | 13 Jan 2003
DCGI asks ICMR to chart guidelines for stem-cell research
By Julie Singh | 13 Jan 2003
IDBI may bid again for strategic sell-off of Hind Antibiotics
By In a recent meeting with | 11 Jan 2003
GlaxoSmithKline declares second interim dividend of 37%
By Our Corporate Bureau | 21 Dec 2002
Sun Pharmaceuticals approves resolutions for split, buyback
By Our Corporate Bureau | 21 Dec 2002
Caraco, Sun Pharma sign R&D pact for 25 new generic drugs
By Caraco reported a record | 09 Dec 2002
Multinational, domestic pharma firms lock horns over R&D data
By Nisha Das | 09 Dec 2002
Ranbaxy to provide AIDS drugs to 10 lakh patients
By New Delhi: | 29 Nov 2002
Gland Pharma sets up R&D centre near Hyderabad
By Our Corporate Bureau | 28 Nov 2002
Alembic gets nod to market third-generation cephalosporin drug
By Suneeta K | 27 Nov 2002
Alembic to diversify into speicalty chemicals, biotechnology
By Suneeta K | 18 Nov 2002
Orchid Chemicals procures USFDA approval for Cephalexin
By Our Corporate Bureau | 11 Nov 2002
Kopran promoters, FIs, banks offload 18% stake in company
By Praveen Chandran | 08 Nov 2002
Novartis acquires global rights for Torrent’s AGE compound
By Suneeta Kaul | 07 Nov 2002
Hikal clocks 28% sales growth at Rs 32 crore in second quarter
By Mumbai: | 31 Oct 2002
Cheryl’s Cosmetics to expand operations, to train professionals
By Venkatachari Jagannathan | 29 Oct 2002
Sun Pharma clocks 12% turnover, 14% PAT increase in Q2
By Our Corporate Bureau | 29 Oct 2002
Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit
By Mumbai: | 18 Oct 2002
Morepen Laboratories net profit up to Rs 168 million in Q2
By Pradeep Rane | 14 Oct 2002
Dr Reddy’s Labs to appeal US court ruling on infringement
By Our Corporate Bureau | 14 Oct 2002
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "Microsoft, Google challenge Delhi HC order to remove non-consensual content")
